Sleep

Nidra Devi Presents New Fall/Winter 2024 Collection During New York Fashion Week

Retrieved on: 
Thursday, February 22, 2024

New York, New York--(Newsfile Corp. - February 22, 2024) - Nidra Devi, founded by Keren Craig, is thrilled to announce the debut presentation of its highly anticipated Fall/Winter 2024 collection at the esteemed NeueHouse Madison Square, during New York Fashion Week.

Key Points: 
  • New York, New York--(Newsfile Corp. - February 22, 2024) - Nidra Devi, founded by Keren Craig, is thrilled to announce the debut presentation of its highly anticipated Fall/Winter 2024 collection at the esteemed NeueHouse Madison Square, during New York Fashion Week.
  • Each look was complimented by the exclusive jewelry collection, Surya and the Moon for Nidra Devi, and shoes provided by Italian shoe designer, Francesca Bellavita.
  • Named after the Hindu goddess of sleep, Nidra Devi was established with a vision to create a collection that reflects a modern, whimsical approach to design.
  • With locations in New York, Hollywood, and Venice Beach, NeueHouse is the preeminent place to create, collaborate and connect.

Real Noise Reduction Technology: BET SLUMBUR Earplugs Debuts on Kickstarter

Retrieved on: 
Monday, March 11, 2024

Shenzhen, China, March 11, 2024 (GLOBE NEWSWIRE) -- BET SLUMBUR is excited to launch its groundbreaking real noise-reducing earplugs on Kickstarter now.

Key Points: 
  • Shenzhen, China, March 11, 2024 (GLOBE NEWSWIRE) -- BET SLUMBUR is excited to launch its groundbreaking real noise-reducing earplugs on Kickstarter now.
  • These real noise reduction earplugs not only have real noise reduction technology but swiftly balance ear pressure in just 15 seconds to help you be happy to use it regularly due to their airy fit design.
  • BET SLUMBUR earplugs with Honeycomb Microporous Crystal Filter designed, the real noise reduction technology have provided a much better listening experience, and allow users to get a calm atmosphere without sacrificing the clarity of important voices at a safer level.
  • BET SLUMBUR's Honeycomb Microporous Crystal Filter doesn't just redefine the real noise reduction for earplugs; it prioritizes comfort and safeguards users' ears and hearing.

Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million

Retrieved on: 
Monday, March 11, 2024

HICKSVILLE, NY, March 11, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Can B Corp., a Florida corporation (OTCQB: CANB) (“Can B”), a health and wellness company specializing in developing, producing and selling hemp-derived cannabinoid products, is pleased to announce that it has secured ownership and control of two cannabis patents that were valued at $122 million, applying a 90% discount and assuming a revenue stream through August 2034, and further based on only CBD claims and only in the U.S. It is believed that if the global THC and CBD markets were added to the valuation, then the value of the patents is potentially up to $750 million.

Key Points: 
  • It is believed that if the global THC and CBD markets were added to the valuation, then the value of the patents is potentially up to $750 million.
  • These patents were previously awarded to United Cannabis Corporation and recently assigned to Can B by a court procedure.
  • The patents were valued at $122 million in December 2020 by an independent third-party valuation team, which used a 90% discount rate due to the emerging nature of the industry.
  • We believe there is a strong opportunity to monetize these patents as they represent important innovations in this industry.

Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in Fibromyalgia

Retrieved on: 
Monday, March 11, 2024

CHATHAM, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced the presentation of additional efficacy data from RESILIENT, the second positive Phase 3 study evaluating Tonmya (also known as TNX-102 SL, cyclobenzaprine HCl sublingual tablets) for the management of fibromyalgia, at the 6th International Congress on Controversies in Fibromyalgia in Brussels, Belgium, March 7-8, 2024.

Key Points: 
  • We now report that the effect sizes of the five continuous key secondary outcomes measures ranged from 0.3 to 0.5.
  • The FIQ-R cognitive item showed nominal improvement in Tonmya-treated patients vs placebo-treated patients with a p=0.001 and effect size of 0.31.
  • RELIEF, the first Phase 3 trial of Tonmya 5.6 mg in fibromyalgia, was completed in December 2020.
  • We also believe the favorable tolerability and side effect profiles will be important to patients and doctors managing this debilitating condition on a long-term basis.”

Cherry Launches Disinfectable Mouse and Keyboard Set for Hygiene-Sensitive Areas at HIMSS

Retrieved on: 
Monday, March 11, 2024

The new hygiene desktop is ideal for extensive entry in hospitals, doctors' surgeries, laboratories, other healthcare facilities, where disinfecting devices is mandatory.

Key Points: 
  • The new hygiene desktop is ideal for extensive entry in hospitals, doctors' surgeries, laboratories, other healthcare facilities, where disinfecting devices is mandatory.
  • When cleaning standard office keyboards, (even when internally sealed) contaminated cleaning fluids can potentially leak out of the gaps.
  • It is also possible the functionality could be impaired if liquids seep into the keyboard housing.
  • The Hygiene Desktop 2 is an individually configurable set consisting of the AK-C8112 hygiene keyboard and the AK-PMH3 3-Button Scroll and AK-PMH3 Scroll Sensor hygienic mice.

New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PT

Retrieved on: 
Thursday, March 7, 2024

First, in October 2023, veterinarians presented SPRYNG™'s positive study results on dogs with cranial cruciate ligament (CCL) disease.

Key Points: 
  • First, in October 2023, veterinarians presented SPRYNG™'s positive study results on dogs with cranial cruciate ligament (CCL) disease.
  • Also, Ethos Veterinary Health, LLC's study on canine hip dysplasia using the product shows success, giving more veterinary doctors information about product uses.
  • PETV's SPRYNG™ with OsteoCushion Technology is a "Game Changer" medical device that successfully treats pets and gives owners options beyond surgeries.
  • New to The Street airs TV Host Jane King's interview with VRM BioLogik® Group's (VRM) Ken Bellamy, Founder and President .

Teladoc Health Expands Obesity & Weight Management Capabilities

Retrieved on: 
Thursday, March 7, 2024

The multidisciplinary care model is designed by clinicians experienced in obesity medicine and delivered with a tailored approach to weight management.

Key Points: 
  • The multidisciplinary care model is designed by clinicians experienced in obesity medicine and delivered with a tailored approach to weight management.
  • Clients can provide their populations with comprehensive and integrated clinical care, that also addresses wellbeing, mental health and social drivers of health in a personalized manner,” said Dr. Vidya Raman-Tangella, Teladoc Health Chief Medical Officer.
  • The Comprehensive Weight Management solution is customized for health plans and employers to meet the needs of their populations and reduce the cost of care for obesity-related medical expenses by going beyond care coordination to deliver:
    An evidence-based, personally tailored approach inclusive of comprehensive support from providers experienced in obesity management, health coaching, medical nutrition therapy, and integrated, highly accessible mental health support.
  • More information on Teladoc Health’s obesity and weight management programs can be found here .

Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask

Retrieved on: 
Wednesday, March 6, 2024

Featuring the AdaptiSeal™ cushion made of 100% soft silicone to adapt to various facial contours, allowing for a secure and comfortable seal throughout the night.

Key Points: 
  • Featuring the AdaptiSeal™ cushion made of 100% soft silicone to adapt to various facial contours, allowing for a secure and comfortable seal throughout the night.
  • The AirFit F40 addresses this problem by providing the necessary pressure support in a more comfortable, lower-profile full-face mask.
  • The mask is ideal for people who sleep on their side, are claustrophobic, and want the stability and seal of a universal fit mask in a minimalist design.
  • AirFit F40 masks are available in the U.S., with plans to launch in Canada, followed by EMEA, Latin America, and APAC.

Nexalin Technology Announces Positive Results from Clinical Study of its Gen-2 tACS Device for Treating Adult Patients with Chronic Insomnia

Retrieved on: 
Wednesday, March 6, 2024

HOUSTON, TEXAS, March 06, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced positive results of a clinical study of its Gen-2 tACS device (“tACS”) for the treatment of chronic insomnia. This clinical study, conducted at Xuanwu Hospital of Capital Medical University in Beijing and Beijing Anding Hospital, evaluated the treatment response of 120 adult participants who were divided into two prespecified age subgroups.

Key Points: 
  • Key data reported from the study suggests that tACS ameliorates chronic insomnia, and that age can impact the extent of the resulting improvement from tACS treatment.
  • Older participants (ages 50 and over) experienced comparatively more significant benefits from tACS, in terms of enhanced sleep quality, efficiency and overall insomnia reduction (p
  • This is attributed to the natural changes in sleep physiology that occur with aging and the distinct manifestations of insomnia symptoms in older individuals.
  • The clinical study’s results, which were published in the Journal of Psychiatric Research, showed that tACS meaningfully reduced the severity of insomnia and enhanced sleep quality and efficiency.

The World Wellness Show, LLC Expands Groundbreaking Educational Health and Wellness TV Show to 137 Countries to Catalyze Global Paradigm Shift 

Retrieved on: 
Tuesday, March 5, 2024

The show is broadcast free in 137 countries, offering viewers a wealth of educational content to inspire a shift from traditional sick care to a focus on holistic well care.

Key Points: 
  • The show is broadcast free in 137 countries, offering viewers a wealth of educational content to inspire a shift from traditional sick care to a focus on holistic well care.
  • Doctors can now effectively promote their passion of holistic wellness messages worldwide.
  • In a world where the importance of well-being is increasingly recognized, as we, the global community, take charge of ensuring this message reaches far and wide.
  • (1) Education can help viewers self-discover the transformative power of a proactive approach to wellness.